このアイテムのアクセス数: 52

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s40780-020-00188-2.pdf510.3 kBAdobe PDF見る/開く
タイトル: Pharmacist-physician collaborative care for outpatients with left ventricular assist devices using a cloud-based home medical management information-sharing system: a case report
著者: Katada, Yoshiki
Yonezawa, Atsushi  KAKEN_id  orcid https://orcid.org/0000-0002-8057-6768 (unconfirmed)
Utsumi, Momoe
Kitada, Noriaki
Sato, Yu-ki
Matsumura, Katsuyuki
Sukeishi, Asami
Nakagawa, Shunsaku  kyouindb  KAKEN_id
Imai, Satoshi  KAKEN_id
Nakagawa, Takayuki  KAKEN_id  orcid https://orcid.org/0000-0003-1890-0843 (unconfirmed)
Minakata, Kenji
Kanemitsu, Hideo
Minatoya, Kenji
Nomoto, Shinichi
Matsubara, Kazuo
著者名の別形: 片田, 佳希
米澤, 淳
北田, 徳昭
佐藤, 夕紀
松村, 勝之
助石, 有沙美
中川, 俊作
今井, 哲司
中川, 貴之
南方, 謙二
金光, ひでお
湊谷, 謙司
野本, 愼一
松原, 和夫
キーワード: Warfarin
Anticoagulation
Pharmacist
Prothrombin time-international normalized ratio
Self-testing
Left ventricular assist device
CoaguCheck® XS
Cloud-based home management system
発行日: 2021
出版者: Springer Nature
BMC
誌名: Journal of Pharmaceutical Health Care and Sciences
巻: 7
論文番号: 5
抄録: [Background] The standard anticoagulation therapy for patients implanted with left ventricular assist devices (LVADs) includes warfarin therapy. We developed a cloud-based home medical management information-sharing system named as LVAD@home. The LVAD@home system is an application designed to be used on iPad tablet computers. This system enables the sharing of daily information between a patient and care providers in real time. In this study, we reported cases of outpatients with LVADs using this system to manage anticoagulation therapy. [Case presentation] The patient, a man in his 40s with end-stage heart failure owing to non-ischemic dilated cardiomyopathy, underwent LVAD implantation and warfarin was started on postoperative day 1. He started to use LVAD@home to manage warfarin therapy after discharge (postoperative day 47). He sent his data to care providers daily. By using this system, the pharmacist observed his signs of reduced dietary intake 179 days after discharge, and after consulting the physician, told the patient to change the timing of the next measurement earlier than usual. On the next day, the prothrombin time-international normalized ratio increased from 2.0 to 3.0, and thus the dose was decreased by 0.5 mg. Four patients used this system to monitor warfarin therapy from October 2015 to March 2018. In these patients, the time in therapeutic range was 90.1 ± 1.3, which was higher than that observed in previous studies. Additionally, there were no thromboembolic events or bleeding events. [Conclusions] The cloud-based home management system can be applied to share real-time patient information of factors, including dietary intake that interact with warfarin. It can help to improve long-term anticoagulation outcomes in patients implanted with LVAD.
著作権等: © The Author(s). 2021
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
URI: http://hdl.handle.net/2433/276094
DOI(出版社版): 10.1186/s40780-020-00188-2
PubMed ID: 33517903
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons